News & Articles

Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration and the next era of regenerative medicine

Discover how the HeadSMART II study is combining blood biomarkers, digital neurocognitive testing and AI to identify patients at risk of persistent TBI symptoms

New portfolio aims to support biosimilar developers accelerate the path to analytical similarity and improve process economics

Q&A with Microbiology in Health and Disease Lead Editor Liang Wang at the Journal of Applied Microbiology

Guest editorial by Maya Carlyle, Principal AI Engineer at the National Physical Laboratory (NPL)

Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them

A new bench-top bioreactor platform with process control designed to support GMP-ready environments from 100 mL to 10 L working volume

Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion

As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions

Delivering reduced hands-on time, more consistent results, and higher sample throughput

The non-invasive test could help clinicians identify women needing urgent hospital investigations while reassuring those unlikely to have womb cancer

Every cell biologist knows the feeling of staring at two identical experiments with different outcomes and wondering whether the answer lies in the biology or the handling

New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested

New tool integrates the entire flow cytometry workflow from panel design to data analysis in one system

IPN60330 is a bispecific antibody engaging MAIT cells, a subset of non-conventional T cells present throughout the body, and the clinically validated tumor antigen GPC3 to kill cancer cells across a variety of solid tumors

Leandro Neves, Senior Global Director of R&D Genomics at LGC, discusses the technologies, challenges, and opportunities shaping the future of genomic analysis

Optimized mRNA constructs are designed for high on-target editing, reduced off-target activity with SpyFi, low toxicity, and delivery method flexibility

Dr. Catherine McKeen of LGC Diagnostics & Genomics - Biosearch Technologies Oligo Synthesis explains how solid support chemistry influences oligonucleotide yield and purity, and how customer collaboration shaped the development of PrimeMax™ CPG

Complementary technologies deliver an integrated, end-to-end clinical flow cytometry workflow for laboratories across Europe

Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development

AI-powered genomic interpretation platform helps laboratories and healthcare systems interpret complex cases faster, reduce manual curation and scale genomic analysis

Hear how the Ocular Tissue Engineering Laboratory is addressing retinal cell culture challenges via an automated stem cell robot platform

Pilot study to develop prototype agentic AI sub-system for initial validation screening of targets identified using AI predictive genomics platform, Nomaly

New survey data reveals what scientists value most when sourcing chemical raw materials, and where Glentham Life Sciences is closing the gaps

Next-generation upgrade strengthens data comparability and compliance—without changing trusted instrumentation